Surveillance and management of recurrence for upper tract transitional cell carcinoma (Q35609567)

9 August 2017

1 reference

title

Surveillance and management of recurrence for upper tract transitional cell carcinoma (English)

1 reference

9 August 2017

Steven E Canfield

1

1 reference

PubMed ID

14680315

9 August 2017

Colin P N Dinney

series ordinal

2

1 reference

PubMed ID

14680315

9 August 2017

Michael J Droller

series ordinal

3

1 reference

9 August 2017

1 November 2003

1 reference

Urologic Clinics of North America

9 August 2017

1 reference

9 August 2017

30

1 reference

9 August 2017

4

1 reference

9 August 2017

791-802

1 reference

Tumors of the upper urinary tract: 10 years of experience

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Tumor grade and stage as prognostic variables in upper tract urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Management of high grade transitional cell cancer of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Risk factors for the development of bladder cancer after upper tract urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Conservative surgery for transitional cell carcinoma of the renal pelvis.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Totally endoscopic management of upper tract transitional-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Laparoscopic nephroureterectomy. A new standard for the surgical management of upper tract transitional cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Evolving management of upper-tract transitional-cell carcinoma at a tertiary-care center

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Conservative surgical management for noninvasive distal ureteral carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Primary percutaneous approach to upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Definitive tumor resection and percutaneous bacille Calmette-Guérin for management of renal pelvic transitional cell carcinoma in solitary kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

The 6.9 F semirigid ureteroscope in clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Urologic applications of the holmium laser: preliminary experience

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Upper-tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Conservative Management of Upper Urinary Tract Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Intravenous urography in urinary tract surveillance in carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Computed tomography of primary transitional cell carcinoma of upper urinary tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Computed tomography for detection and staging of transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Transitional cell carcinoma of the renal pelvis: a retrospective look at CT staging with pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Conventional CT signs in staging transitional cell tumors of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Use of magnetic resonance urography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Magnetic resonance urography enhanced by gadolinium and diuretics: a comparison with conventional urography in diagnosing the cause of ureteric obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Urinary cytology and the clinical diagnosis of urinary tract malignancy: a clinicopathologic study of 1,400 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Utility of the Bard BTA test in detecting upper urinary tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Limitations of ureteroscopy in diagnosis of invasive upper tract urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Conservative treatment of upper urinary tract tumors with Nd:YAG laser

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Prognostic Factors in Carcinoma of the Ureter

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Use of p53 in the diagnosis of upper-tract transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Grading of upper urinary tract transitional cell carcinoma by computed DNA content and p53 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Cytogenetic investigation of transitional cell carcinomas of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Upper tract tumors in patients with primary bladder cancer followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

The role of systemic chemotherapy in the management of muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2803%2900062-4

7 January 2021

10.1016/S0094-0143(03)00062-4

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14680315